Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase [language] = "en-us"

Di |2021-11-04T23:00:00+01:00Novembre 4th, 2021|Categorie: Coronavirus NEJM|

The global morbidity, mortality, and societal disruption caused by the coronavirus disease 2019 (Covid-19) pandemic prompted accelerated clinical vaccine development and regulatory interventions to mitigate some of its consequences. Between December 20...